60 Citations
Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes
- MedicineThe journals of gerontology. Series A, Biological sciences and medical sciences
- 2016
This article summarizes the outcomes of an international meeting partly funded through the NIH R24 Geroscience Network, whose purpose was to generate concepts and frameworks for early, proof-of-concept clinical trials for therapeutic interventions that target fundamental processes of aging.
A Bayesian Method for the Detection of Proof of Concept in Early Phase Oncology Studies with a Basket Design
- MathematicsStatistics in Biosciences
- 2020
A novel approach for PoC detection in the early phase basket trials under a Bayesian framework is proposed, and results show that the proposed approach has a promising performance, with considerable gain in power compared with the independent approach when a relatively large number of the cancer types are sensitive to the treatment.
Proof‐of‐Principle/Proof‐of‐Concept Trials in Drug Development
- Biology
- 2010
The biomarkers, pharmacogenomics, proteomics, metabonomics, medical imaging, pharmacological models, and nonpharmacological models in PoP/PoC trials are focused on.
Exenatide and the treatment of patients with Parkinson's disease.
- MedicineThe Journal of clinical investigation
- 2013
These results demonstrate a potential cost-efficient approach through which preliminary clinical data of possible biological effects are obtainable, prior to undertaking the major investment required for double-blind trials of a potential disease-modifying drug in PD.
How predictive are photosensitive epilepsy models as proof of principle trials for epilepsy?
- Medicine, PsychologySeizure
- 2014
Exenatide as a novel treatment for Parkinson's Disease
- Medicine, Biology
- 2013
The aim of this thesis is the evaluation of Exenatide’s possible role as a potential neuroprotective/disease modifying agent in PD with only preliminary insights regarding its mechanisms of action in neurodegeneration.
Drugs’ development in acute heart failure: what went wrong?
- MedicineHeart Failure Reviews
- 2018
This review has reviewed the data published on drugs developed for AHF since early 2000s, trying to recognise factors that have worked for a successful approval or for the stoppage of the program, in an attempt to delineate future trajectories forAHF drug development.
Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: Dose-dependent effects in the human photosensitivity model
- Medicine, BiologyEpilepsy & Behavior
- 2013
Efficacy and Safety of Pirfenidone in Patients with Second-Degree Burns: A Proof-of-Concept Randomized Controlled Trial
- MedicineAdvances in skin & wound care
- 2020
A decrease in wound healing time by enhancing wound re-epithelialization was observed with pirfenidone, and Histologic evaluations showed less wound fibrosis in the pirfenodone group.
References
SHOWING 1-6 OF 6 REFERENCES
A new approach in anti‐epileptic drug evaluation
- Medicine, PsychologyEuropean journal of neurology
- 2004
A complete withdrawal of AEDs should be avoided and a titration phase limited to 3 days is suggested, using a condensed evaluation setting including the TISA method, serum concentration and neuropsychological monitoring, by which AED efficacy on seizure activity can be objectively quantified by using continuous video‐EEG monitoring.
Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam
- Medicine, PsychologyEpilepsy Research
- 1996
A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures
- Medicine, PsychologyEpilepsy Research
- 1990
Transcranial magnetic stimulation (TMS)
- Psychology, MedicineThe Australian and New Zealand journal of psychiatry
- 1995
Professional Institutional Original Effective Date: November 1, 2011 Original Effective Date: November 1, 2011 Revision Date(s): December 7, 2012; May 7, 2013; October 15, 2014; March 18, 2015;…